$VRSN
VeriSign, Inc Stock $vrsn

$vrsn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000101447324000023 Filed on April 25, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$387.1M	$384.3M
YoY Change	4.06%	5.46%
Cost Of Revenue	$47.10M	$49.10M
YoY Change	-6.36%	-1.6%
Gross Profit	$340.0M	$335.2M
YoY Change	5.69%	6.58%
Gross Profit Margin	87.83%	87.22%
Selling, General & Admin	$50.00M	$51.50M
YoY Change	-1.57%	5.1%
% of Gross Profit	14.71%	15.36%
Research & Development	$23.80M	$24.80M
YoY Change	7.21%	2.48%
% of Gross Profit	7.0%	7.4%
Depreciation & Amortization	$9.300M	$9.800M
YoY Change	-17.7%	-15.52%
% of Gross Profit	2.74%	2.92%
Operating Expenses	$73.80M	$76.30M
YoY Change	1.1%	4.23%
Operating Profit	$266.2M	$258.9M
YoY Change	7.04%	7.29%
Interest Expense	$18.80M	-$18.80M
YoY Change	-199.47%	-200.0%
% of Operating Profit	7.06%	-7.26%
Other Income/Expense, Net	$11.50M	$13.90M
YoY Change	-9.45%	23.01%
Pretax Income	$258.9M	$254.0M
YoY Change	6.76%	8.64%
Income Tax	$60.10M	$59.90M
% Of Pretax Income	23.21%	23.58%
Net Earnings	$198.8M	$194.1M
YoY Change	7.05%	8.62%
Net Earnings / Revenue	51.36%	50.51%
Basic Earnings Per Share
Diluted Earnings Per Share	$2.01	$1.92
COMMON SHARES
Basic Shares Outstanding	99.60M shares	100.9M shares
Diluted Shares Outstanding	99.00M shares	100.9M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$689.9M	$924.7M
YoY Change	-26.26%	-8.9%
Cash & Equivalents	$252.2M	$731.8M
Short-Term Investments	$437.7M	$192.9M
Other Short-Term Assets	$71.30M	$55.70M
YoY Change	29.87%	-4.13%
Inventory
Prepaid Expenses
Receivables	$3.600M	$6.500M
Other Receivables	$11.00M	$1.400M
Total Short-Term Assets	$761.2M	$988.3M
YoY Change	-23.68%	-7.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$227.8M	$234.6M
YoY Change	-0.26%	4.31%
Goodwill	$52.50M	$52.50M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$38.80M	$452.4M
YoY Change	-90.27%	1465.4%
Total Long-Term Assets	$743.9M	$739.5M
YoY Change	9.43%	8.13%
TOTAL ASSETS
Total Short-Term Assets	$761.2M	$988.3M
Total Long-Term Assets	$743.9M	$739.5M
Total Assets	$1.505B	$1.728B
YoY Change	-10.26%	-1.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.000M	$9.400M
YoY Change	18.42%	42.42%
Accrued Expenses	$87.70M	$83.70M
YoY Change	0.92%	0.12%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.191B	$1.214B
YoY Change	4.34%	3.63%
LONG-TERM LIABILITIES
Long-Term Debt	$1.791B	$1.791B
YoY Change	0.13%	0.12%
Other Long-Term Liabilities	$17.30M	$358.9M
YoY Change	-95.25%	477.01%
Total Long-Term Liabilities	$2.130B	$2.150B
YoY Change	-1.08%	-1.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.191B	$1.214B
Total Long-Term Liabilities	$2.130B	$2.150B
Total Liabilities	$3.322B	$3.364B
YoY Change	0.8%	0.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.99B	-$13.19B
YoY Change	-6.11%	-5.94%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$14.31B	$13.92B
YoY Change	8.41%	7.24%
Treasury Stock Shares
Shareholders Equity	-$1.816B	-$1.636B
YoY Change
Total Liabilities & Shareholders Equity	$1.505B	$1.728B
YoY Change	-10.26%	-1.66%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$198.8M	$194.1M
YoY Change	7.05%	8.62%
Depreciation, Depletion And Amortization	$9.300M	$9.800M
YoY Change	-17.7%	-15.52%
Cash From Operating Activities	$160.4M	$257.3M
YoY Change	10.39%	-0.66%
INVESTING ACTIVITIES
Capital Expenditures	$9.200M	$3.800M
YoY Change	41.54%	-33.33%
Acquisitions
YoY Change
Other Investing Activities	-$240.7M	$500.2M
YoY Change	-38.57%	20.39%
Cash From Investing Activities	-$249.9M	$496.4M
YoY Change	-37.26%	21.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-390.3M	-261.6M
YoY Change	75.1%	17.57%
NET CHANGE
Cash From Operating Activities	160.4M	257.3M
Cash From Investing Activities	-249.9M	496.4M
Cash From Financing Activities	-390.3M	-261.6M
Net Change In Cash	-479.8M	492.1M
YoY Change	0.82%	10.31%
FREE CASH FLOW
Cash From Operating Activities	$160.4M	$257.3M
Capital Expenditures	$9.200M	$3.800M
Free Cash Flow	$151.2M	$253.5M
YoY Change	8.93%	0.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	49100000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	49900000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24800000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24200000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	51500000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49000000.0	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	125400000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	123100000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	258900000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	241300000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	18800000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	18800000	usd
CY2024Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	13900000	usd
CY2023Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	11300000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	254000000.0	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	233800000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	59900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55100000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	194100000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	178700000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-200000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	193900000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	178700000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.93
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.70
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.92
CY2023Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.70
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100800000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104900000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	100900000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000.0	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1581000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1562200000	usd
CY2024Q1	vrsn	Excise Tax On Repurchase Of Common Stock ExciseTaxOnRepurchaseOfCommonStock	2300000	usd
CY2023Q1	vrsn	Excise Tax On Repurchase Of Common Stock ExciseTaxOnRepurchaseOfCommonStock	1900000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1635700000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1593800000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	194100000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	178700000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9800000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11600000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	15100000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	13800000	usd
CY2024Q1	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	7000000.0	usd
CY2023Q1	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	4000000.0	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1000000.0	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1100000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4100000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1900000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8000000.0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12100000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	38600000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	41800000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-17800000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-2000000.0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	257300000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	259000000.0	usd
CY2024Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	658000000.0	usd
CY2023Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	562000000.0	usd
CY2024Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	157800000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	146500000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3800000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5700000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	496400000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	409800000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	269900000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	230500000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	8300000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	8000000.0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-261600000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-222500000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-400000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-200000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	491700000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	446100000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	245500000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	379000000.0	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	737200000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	825100000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	13100000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	13100000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	16100000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	18300000	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	23600000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	25600000	usd
CY2024Q1	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	1900000	usd
CY2023Q4	us-gaap	Time Deposits At Carrying Value TimeDepositsAtCarryingValue	1000000.0	usd
CY2024Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	202500000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	160300000	usd
CY2024Q1	us-gaap	Financial Instruments Owned Us Government And Agency Obligations At Fair Value FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue	702100000	usd
CY2023Q4	us-gaap	Financial Instruments Owned Us Government And Agency Obligations At Fair Value FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue	744900000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	930100000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	931800000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	731800000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240100000	usd
CY2024Q1	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	5400000	usd
CY2023Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	5400000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	737200000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	245500000	usd
CY2024Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	192900000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	686300000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	930100000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	931800000	usd
CY2024Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	1670000000	usd
CY2023Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	1690000000	usd
CY2023Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	77200000	usd
CY2024Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	83700000	usd
CY2023Q4	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	49500000	usd
CY2024Q1	us-gaap	Customer Deposits Current CustomerDepositsCurrent	66900000	usd
CY2024Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	25300000	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	23300000	usd
CY2024Q1	vrsn	Prepaidregistryfeescurrent Prepaidregistryfeescurrent	24100000	usd
CY2023Q4	vrsn	Prepaidregistryfeescurrent Prepaidregistryfeescurrent	23800000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6500000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6300000	usd
CY2024Q1	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	5300000	usd
CY2023Q4	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	0	usd
CY2024Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	1400000	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	7300000	usd
CY2024Q1	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	1000000.0	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	1200000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	63600000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	61900000	usd
CY2024Q1	vrsn	Prepaid Registry Fees Non Current PrepaidRegistryFeesNonCurrent	8300000	usd
CY2023Q4	vrsn	Prepaid Registry Fees Non Current PrepaidRegistryFeesNonCurrent	8300000	usd
CY2024Q1	vrsn	Operating Lease Rou OperatingLeaseROU	7400000	usd
CY2023Q4	vrsn	Operating Lease Rou OperatingLeaseROU	7400000	usd
CY2024Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	7200000	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	4800000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	5400000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	5400000	usd
CY2024Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	3300000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	3100000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	31600000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	29000000.0	usd
CY2024Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	9400000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	12500000	usd
CY2024Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	38200000	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	61200000	usd
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	24600000	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	19500000	usd
CY2024Q1	vrsn	Accruedfees Accruedfees	13700000	usd
CY2023Q4	vrsn	Accruedfees Accruedfees	12300000	usd
CY2024Q1	vrsn	Customer Incentives Payable CustomerIncentivesPayable	6200000	usd
CY2023Q4	vrsn	Customer Incentives Payable CustomerIncentivesPayable	6500000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5000000.0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5100000	usd
CY2024Q1	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	0	usd
CY2023Q4	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	10700000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2200000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2900000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	249900000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	257400000	usd
	vrsn	Additionalsharerepurchaseamountauthorized Additionalsharerepurchaseamountauthorized	1140000000	usd
CY2023Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	356100000	usd
CY2023Q3	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1500000000	usd
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	859600000	usd
CY2024Q1	vrsn	Treasury Stock Shares Repurchased TreasuryStockSharesRepurchased	1300000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	260400000	usd
CY2024Q1	vrsn	Treasury Stock Shares Repurchased Average Cost Per Share TreasuryStockSharesRepurchasedAverageCostPerShare	196.37
CY2024Q1	vrsn	Treasury Stock Shares Repurchased For Tax Withholding And Other TreasuryStockSharesRepurchasedForTaxWithholdingAndOther	0	usd
CY2024Q1	vrsn	Treasury Stock Value Repurchased For Tax Withholding TreasuryStockValueRepurchasedForTaxWithholding	9500000	usd
CY2024Q1	vrsn	Total Repurchases For Tax Withholdings And Other Average Cost Per Share TotalRepurchasesForTaxWithholdingsAndOtherAverageCostPerShare	197.84
CY2024Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1400000	shares
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	269900000	usd
CY2024Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	196.42
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	254900000	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	13920000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100800000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104900000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	100000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	100000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	100900000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105000000.0	shares
CY2024Q1	us-gaap	Revenues Revenues	384300000	usd
CY2023Q1	us-gaap	Revenues Revenues	364400000	usd
CY2024Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	343000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	15100000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	13800000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	200000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	300000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	15300000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	14100000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	15300000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	14100000	usd
CY2024Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	12000000	usd
CY2023Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	10700000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	59900000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	55100000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.24	rate
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.24	rate
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	rate
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001014473-24-000023-index-headers.html	Edgar Link	pending
0001014473-24-000023-index.html	Edgar Link	pending
0001014473-24-000023.txt	Edgar Link	pending
0001014473-24-000023-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrsn-20240331.htm	Edgar Link	pending
vrsn-20240331.xsd	Edgar Link	pending
vrsn-2024331x10qxex3101.htm	Edgar Link	pending
vrsn-2024331x10qxex3102.htm	Edgar Link	pending
vrsn-2024331x10qxex3201.htm	Edgar Link	pending
vrsn-20240331_def.xml	Edgar Link	unprocessable
vrsn-20240331_lab.xml	Edgar Link	unprocessable
vrsn-20240331_pre.xml	Edgar Link	unprocessable
vrsn-20240331_htm.xml	Edgar Link	completed
vrsn-2024331x10qxex3202.htm	Edgar Link	pending
vrsn-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRSN
VeriSign, Inc Stock $vrsn

2024 Q2 Form 10-Q Financial Statement

#000101447324000023 Filed on April 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRSN VeriSign, Inc Stock $vrsn

2024 Q2 Form 10-Q Financial Statement

#000101447324000023 Filed on April 25, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRSN
VeriSign, Inc Stock $vrsn